These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 19197564)

  • 1. European consensus table on the use of botulinum toxin type A in adult spasticity.
    Wissel J; Ward AB; Erztgaard P; Bensmail D; Hecht MJ; Lejeune TM; Schnider P; Altavista MC; Cavazza S; Deltombe T; Duarte E; Geurts AC; Gracies JM; Haboubi NH; Juan FJ; Kasch H; Kätterer C; Kirazli Y; Manganotti P; Parman Y; Paternostro-Sluga T; Petropoulou K; Prempeh R; Rousseaux M; Slawek J; Tieranta N
    J Rehabil Med; 2009 Jan; 41(1):13-25. PubMed ID: 19197564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigating muscle selection for botulinum toxin-A injections in adults with post-stroke upper limb spasticity.
    Baguley IJ; Nott MT; Turner-Stokes L; De Graaff S; Katrak P; McCrory P; de Abadal M; Hughes A
    J Rehabil Med; 2011 Nov; 43(11):1032-7. PubMed ID: 22031350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Using botulinum toxin (Botox) for treatment of patients with postroke spasticity].
    Khat'kova SE
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(6):87-90. PubMed ID: 19685598
    [No Abstract]   [Full Text] [Related]  

  • 4. Evidence-based review and assessment of botulinum neurotoxin for the treatment of adult spasticity in the upper motor neuron syndrome.
    Esquenazi A; Albanese A; Chancellor MB; Elovic E; Segal KR; Simpson DM; Smith CP; Ward AB
    Toxicon; 2013 Jun; 67():115-28. PubMed ID: 23220492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of botulinum toxin type a in the treatment of post-stroke spasticity.
    Ward A; Roberts G; Warner J; Gillard S
    J Rehabil Med; 2005 Jul; 37(4):252-7. PubMed ID: 16024483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measuring spasticity and fine motor control (pinch) change in the hand after botulinum toxin-A injection using dynamic computerized hand dynamometry.
    Barden HL; Baguley IJ; Nott MT; Chapparo C
    Arch Phys Med Rehabil; 2014 Dec; 95(12):2402-9. PubMed ID: 24909588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potentiation of botulinum toxin type A with oral anti-spasticity medications in the management of focal spasticity.
    Dai A
    J Rehabil Med; 2007 Mar; 39(2):189; author reply 189. PubMed ID: 17351705
    [No Abstract]   [Full Text] [Related]  

  • 8. High doses of incobotulinumtoxinA for the treatment of post-stroke spasticity: are they safe and effective?
    Santamato A; Ranieri M; Solfrizzi V; Lozupone M; Vecchio M; Daniele A; Greco A; Seripa D; Logroscino G; Panza F
    Expert Opin Drug Metab Toxicol; 2016 Aug; 12(8):843-6. PubMed ID: 27291256
    [No Abstract]   [Full Text] [Related]  

  • 9. Intrafusal effects of botulinum toxin injections for spasticity: revisiting a previous paper.
    Phadke CP; On AY; Kirazli Y; Ismail F; Boulias C
    Neurosci Lett; 2013 Apr; 541():20-3. PubMed ID: 23458671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of treatment with incobotulinum toxin A (botulinum neurotoxin type A free from complexing proteins; NT 201) in post-stroke upper limb spasticity.
    Kaňovský P; Slawek J; Denes Z; Platz T; Comes G; Grafe S; Pulte I
    J Rehabil Med; 2011 May; 43(6):486-92. PubMed ID: 21533328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
    Wissel J; Entner T
    Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of incobotulinum toxin type A (NT 201-Xeomin) for the treatment of post-stroke lower limb spasticity: a prospective open-label study.
    Santamato A; Micello MF; Panza F; Fortunato F; Pilotto A; Giustini A; Testa A; Fiore P; Ranieri M; Spidalieri R
    Eur J Phys Rehabil Med; 2013 Aug; 49(4):483-9. PubMed ID: 23480980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of focal upper limb spasticity with botulinum toxin after stroke. Interest of an individual approach].
    Luauté J; Landrault E; Jacquin-Courtois S; Mertens P; Rode G; Boisson D
    Ann Readapt Med Phys; 2004 Oct; 47(8):555-62. PubMed ID: 15465160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Employment of higher doses of botulinum toxin type A to reduce spasticity after stroke.
    Santamato A; Micello MF; Ranieri M; Valeno G; Albano A; Baricich A; Cisari C; Intiso D; Pilotto A; Logroscino G; Panza F
    J Neurol Sci; 2015 Mar; 350(1-2):1-6. PubMed ID: 25684341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of neural lesion type on botulinum toxin dosage: a retrospective chart review.
    Phadke CP; Davidson C; Ismail F; Boulias C
    PM R; 2014 May; 6(5):406-11. PubMed ID: 24211697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel approach to the application of botulinum toxin to the flexor digitorum superficialis muscle in acquired brain injury.
    Munin MC; Navalgund BK; Levitt DA; Breisinger TP; Zafonte RD
    Brain Inj; 2004 Apr; 18(4):403-7. PubMed ID: 14742153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and self-reported efficacy of botulinum toxin for adult spasticity in current clinical practice: a prospective observational study.
    Muller F; Cugy E; Ducerf C; Delleci C; Guehl D; Joseph PA; Burbaud P; Dehail P
    Clin Rehabil; 2012 Feb; 26(2):174-9. PubMed ID: 21937525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short Form 36 assessed health-related quality of life after focal spasticity therapy.
    Bergfeldt U; Sköld C; Julin P
    J Rehabil Med; 2009 Mar; 41(4):279-81. PubMed ID: 19247549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of intrathecal baclofen, botulinum toxin type A and a rehabilitation programme on locomotor function after spinal cord injury: a case report.
    Santamato A; Panza F; Ranieri M; Amoruso MT; Amoruso L; Frisardi V; Solfrizzi V; Fiore P
    J Rehabil Med; 2010 Oct; 42(9):891-4. PubMed ID: 20878052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Delphi-Based Consensus Statement on the Management of Anticoagulated Patients With Botulinum Toxin for Limb Spasticity.
    Boulias C; Ismail F; Phadke CP; Bagg S; Bureau I; Charest S; Chen R; Cheng A; Ethans K; Fink M; Finlayson H; Gulasingam S; Guo M; Haziza M; Hosseini H; Khan O; Lang M; Lapp T; Leckey R; Li Pi Shan R; Liem N; Lo A; Mason M; McNeil S; McVeigh S; Miller T; Mills PB; Naud P; O'Connell C; Petitclerc M; Prevost J; Reebye R; Richardson D; Satkunam L; Sharma S; Short C; Sirois G; Unarket M; Wein T; Wilkins K; Winston P
    Arch Phys Med Rehabil; 2018 Nov; 99(11):2183-2189. PubMed ID: 29803825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.